This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hung, S.-C. Articles by Gelovani, J. G. Search for Related Content PubMed PubMed Citation Articles by Hung, S.-C. Articles by Gelovani, J. G.

Mesenchymal Stem Cell Targeting of Microscopic Tumors and Tumor Stroma Development Monitored by Noninvasive In vivo Positron Emission Tomography Imaging

Authors' Affiliations: ¹ Institute of Biomedical Sciences, Academia Sinica, Nankang; ² Institute of Biomedical Materials, Taipei Medical University; Departments of ³ Medical Research, Orthopedics, and ⁴ Nuclear Medicine and National PET Cyclotron Center, Veterans General Hospital-Taipei; ⁵ School of Medicine, National Yang-Ming University, Taipei, Taiwan; and ⁶ Laboratory of Cell/Gene Therapy, China Medical University Hospital, Taichung, Taiwan; ⁷ Department of Experimental Diagnostic Imaging, University of Texas M.D. Anderson Cancer Center, Houston, Texas

Requests for reprints: Juri G. Gelovani, Department of Experimental Diagnostic Imaging, University of Texas M.D. Anderson Cancer Center, Unit 057, 1515 Holcombe Boulevard, Houston, TX 77030. Phone: 713-563-3343; Fax: 713-563-4894; E-mail: jgelovani{at}mdanderson.org.

The aim of this study was to assess the efficacy human mesenchymal stem cells (hMSC) for targeting microscopic tumors and suicide gene or cytokine gene therapy. Immunodeficient mice were transplanted s.c. with human colon cancer cells of HT-29 Inv2 or CCS line, and 3 to 4 days later, i.v. with "tracer" hMSCs expressing herpes simplex virus type 1 thymidine kinase (HSV1-TK) and enhanced green fluorescent protein (EGFP) reporter genes. Subsequently, these tumors were examined for specificity and magnitude of HSV1-TK⁺, EGFP⁺ stem cell engraftment and proliferation in tumor stroma by in vivo positron emission tomography (PET) with ¹⁸F-labeled 9-(4-fluoro-3-hydroxymethylbutyl)-guanine ([¹⁸F]-FHBG). In vivo PET images of tumors growing for 4 weeks showed the presence of HSV1-TK⁺ tumor stroma with an average of 0.36 ± 0.24% ID/g [¹⁸F]-FHBG accumulation. In vivo imaging results were validated by in situ correlative histochemical, immunofluorescent, and cytometric analyses, which revealed EGFP expression in vWF⁺ and CD31⁺ endothelial cells of capillaries and larger blood vessels, in germinal layer of dermis and hair follicles proximal to the s.c. tumor site. These differentiated HSV1-TK⁺, GFP⁺ endothelial cells had limited proliferative capacity and a short life span of <2 weeks in tumor fragments transplanted into secondary hosts. We conclude that hMSCs can target microscopic tumors, subsequently proliferate and differentiate, and contribute to formation of a significant portion of tumor stroma. PET imaging should facilitate clinical translation of stem cell–based anticancer gene therapeutic approaches by providing the means for in vivo noninvasive whole-body monitoring of trafficking, tumor targeting, and proliferation of HSV1-tk-expressing "tracer" hMSCs in tumor stroma.

This article has been cited by other articles:

				W.-C. Lo, C.-H. Hsu, A. T.H. Wu, L.-Y. Yang, W.-H. Chen, W.-T. Chiu, W.-F. Lai, C.-H. Wu, J. G. Gelovani, and W.-P. Deng A Novel Cell-Based Therapy for Contusion Spinal Cord Injury Using GDNF-Delivering NIH3T3 Cells with Dual Reporter Genes Monitored by Molecular Imaging J. Nucl. Med., September 1, 2008; 49(9): 1512 - 1519. [Abstract] [Full Text] [PDF]

				Z. Lee, J. E. Dennis, and S. L. Gerson Imaging Stem Cell Implant for Cellular-Based Therapies Experimental Biology and Medicine, August 1, 2008; 233(8): 930 - 940. [Abstract] [Full Text] [PDF]

				P. J. Mishra, P. J. Mishra, R. Humeniuk, D. J. Medina, G. Alexe, J. P. Mesirov, S. Ganesan, J. W. Glod, and D. Banerjee Carcinoma-Associated Fibroblast-Like Differentiation of Human Mesenchymal Stem Cells Cancer Res., June 1, 2008; 68(11): 4331 - 4339. [Abstract] [Full Text] [PDF]

				Z. Love, F. Wang, J. Dennis, A. Awadallah, N. Salem, Y. Lin, A. Weisenberger, S. Majewski, S. Gerson, and Z. Lee Imaging of Mesenchymal Stem Cell Transplant by Bioluminescence and PET J. Nucl. Med., December 1, 2007; 48(12): 2011 - 2020. [Abstract] [Full Text] [PDF]

				L. Kucerova, V. Altanerova, M. Matuskova, S. Tyciakova, and C. Altaner Adipose Tissue-Derived Human Mesenchymal Stem Cells Mediated Prodrug Cancer Gene Therapy Cancer Res., July 1, 2007; 67(13): 6304 - 6313. [Abstract] [Full Text] [PDF]

				H. Xin, M. Kanehira, H. Mizuguchi, T. Hayakawa, T. Kikuchi, T. Nukiwa, and Y. Saijo Targeted Delivery of CX3CL1 to Multiple Lung Tumors by Mesenchymal Stem Cells Stem Cells, July 1, 2007; 25(7): 1618 - 1626. [Abstract] [Full Text] [PDF]

				S. G. Ball, C. A. Shuttleworth, and C. M. Kielty Vascular endothelial growth factor can signal through platelet-derived growth factor receptors J. Cell Biol., May 7, 2007; 177(3): 489 - 500. [Abstract] [Full Text] [PDF]

				V. Ponomarev, M. Doubrovin, A. Shavrin, I. Serganova, T. Beresten, L. Ageyeva, C. Cai, J. Balatoni, M. Alauddin, and J. Gelovani A Human-Derived Reporter Gene for Noninvasive Imaging in Humans: Mitochondrial Thymidine Kinase Type 2 J. Nucl. Med., May 1, 2007; 48(5): 819 - 826. [Abstract] [Full Text] [PDF]

				X.-c. Chen, R. Wang, X. Zhao, Y.-q. Wei, M. Hu, Y.-s. Wang, X.-w. Zhang, R. Zhang, L. Zhang, B. Yao, et al. Prophylaxis against carcinogenesis in three kinds of unestablished tumor models via IL12-gene-engineered MSCs Carcinogenesis, December 1, 2006; 27(12): 2434 - 2441. [Abstract] [Full Text] [PDF]

				W.-P. Deng, C.-C. Wu, C.-C. Lee, W. K. Yang, H.-E. Wang, R.-S. Liu, H.-J. Wei, J. G. Gelovani, J.-J. Hwang, D.-M. Yang, et al. Serial In Vivo Imaging of the Lung Metastases Model and Gene Therapy Using HSV1-tk and Ganciclovir J. Nucl. Med., May 1, 2006; 47(5): 877 - 884. [Abstract] [Full Text] [PDF]